[Hospitalization for infection in patients treated for giant cell arteritis: A single-centre retrospective study]

P Lavrard-Meyer1, Q Gomes De Pinho1, A Daumas2

  • 1Assistance Publique des hôpitaux de Marseille (APHM), hôpital Nord, service de médecine interne, Aix-Marseille Université (AMU), Marseille, France.

La Revue De Medecine Interne
|April 7, 2023
PubMed

Insights

Infections increase mortality in giant cell arteritis (GCA) patients. This study identified risk factors for infection and found seritis was more common in infected patients, while GCA relapses were less frequent.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Infections are a significant cause of morbidity and mortality in patients with giant cell arteritis (GCA).
  • Understanding factors contributing to infection risk is crucial for managing GCA patients.
  • Previous studies highlight the association between GCA and increased susceptibility to infections.

Purpose of the Study:

  • To identify factors predisposing to infection risk in GCA patients.
  • To describe characteristics of GCA patients hospitalized with infections during treatment.
  • To analyze the clinical presentation and outcomes of infections in GCA.

Main Methods:

  • A monocentric retrospective study compared GCA patients hospitalized for infection (cases) with matched controls (no infection).
  • The study included 21 patients with 26 infections and 42 control patients.
  • Matching criteria included sex, age, and GCA diagnosis.

Main Results:

  • Patients with infections showed a higher frequency of seritis (15% vs. 0%, p=0.03) compared to controls.
  • GCA relapses were less frequent in patients with infections (23.8% vs. 50.0%, p=0.041).
  • Hypogammaglobulinemia was observed during infection; over half of infections occurred within the first year of treatment with average 15mg/day corticosteroids. Pulmonary (46.2%) and cutaneous (26.9%) infections were most common.

Conclusions:

  • Key factors associated with infectious risk in GCA patients were identified.
  • This preliminary study underscores the need for further investigation into infection management in GCA.
  • Findings will inform a larger, national multicenter study on GCA-associated infections.
Abstract

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
23
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
14
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
10
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
10
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
20
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
18